Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype

Pharmacogenetics

Volumn 10, Issue 5, 2000, Pages 461-469

  Delfino, Ralph J ^a   Smith, Cynthia ^a   West, John G ^b   Henry J, Lin ^c   White, Edward ^d   Liao, Shu Yuan ^a   Gim, Jason S Y ^c   Ma, Hoang L ^c   Butler, John ^a   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Breast Care Center   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Saddleback Breast Center   (United States)

Author keywords

Benign breast disease; Breast cancer; NAT2 gene; Smoking

Indexed keywords

ACYLTRANSFERASE;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; BREAST DISEASE; BREAST HYPERPLASIA; CANCER RISK; CARCINOMA IN SITU; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PASSIVE SMOKING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MIDDLE AGED; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 0033947721     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200007000-00009     Document Type: Article

References (51)

1. Agúndez JA, Ladero JM, Olivera M, Abildúa R, Román JM, Benítez J. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology 1995; 52:7-11.
2. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996; 276:1494-1501.
3. Baker LH, Chin DY, Wagner KV. Progress in screening for early breast cancer. J Surg Oncol 1995; 30:96-102.
4. Baron JA. Smoking and estrogen-related disease. Am J Epidemiol 1984; 119:9-22.
5. Baron JA. Smoking and estrogen-related disease in women. In: Rosenberg MJ. ed. Smoking and reproductive health. Littleton, MA: PSG; 1987, pp. 149-166.
6. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990; 162:502-514.
7. Baron JA, Newcomb PA, Longnecker MP, Mittendorf R, Storer BE, Clapp RW, et al. Cigarette smoking and breast cancer. Cancer Epidemiol Biomark Prev 1996; 5:399-403.
8. Bell GI, Karam JH, Rutter WJ. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci USA 1981; 78:5759-5763.
9. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993; 14:1689-1692.
10. Berkowitz GS, Canny PF, Vivolsi VA, Merino MJ, O'Connor TZ, Kelsey JL. Cigarette smoking and benign breast disease. J Epidemiol Commun Health 1985; 39:308-313.
11. Bernstein L, Pike MC, Lobo RA, Depue RH, Ross RK, Henderson BE. Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels. Br J Obstet Gynaecol 1989; 96:92-96.
12. Blum M, Grant DM, McBride OW, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization and functional expression. DNA Cell Biol 1990; 9:193-203.
13. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG. Prognostic significance of benign proliferative breast disease. Cancer 1993; 71:3896-3907.
14. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16 692 women with benign breast disease. Am J Epidemiol 1988; 128:467-477.
15. Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993; 71:1258-1265.
16. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD, Rados MS, Schuyler PA. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994; 331:10-15.
17. Ebisawa T, Deguchi T. Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases. Biochem Biophys Res Commun 1991; 177:1252-1257.
18. Geever RF, Wilson LB, Nallaseth FS, Milner PF, Bittner M, Wilson JT. Direct identification of sickle cell anemia by blot hybridization. Proc Natl Acad Sci USA 1981; 78:5081-5085.
19. Grant DM, Blum M, Beer M, Meyer UA. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 1991; 39:184-191.
20. Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 1988; 948:37-66.
21. Hershcopf RJ, Bradlow HL. Obesity, diet, endogenous estrogens and the risk of hormone-sensitive cancers. Am J Clin Nutr 1987; 45:283-289.
22. Hiatt RA, Fireman BH. Smoking, menopause, and breast cancer. J Natl Cancer Inst 1986; 76:833-838.
23. Hunter DJ, Hankinson SE, Hough H, Gertig DM, Garcia-Closas M, Spiegelman D, et al. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis 1997; 18:2127-2132.
24. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases: variation by histologic type, degree of atypia, age of biopsy, and length of follow-up. Am J Epidemiol 1992; 135:619-631.
25. Lash TL, Aschengrau A. Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol 1999; 149:5-12.
26. Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 1996; 56:287-293.
27. Lin HJ, Han C-Y, Lin BK, Hardy S. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 798 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. Am J Hum Genet 1993; 52:827-834.
28. Lin HJ, Han C-Y, Link, Lin BK, Hardy S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1994; 4:125-134.
29. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992; 267:941-944.
30. Want D, Vessey MP, Smith MA, Yeates D. Cigarette smoking and benign breast disease. J Epidemiol Commun Health 1986; 40:277.
31. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New Engl J Med 1986; 315:1305-1309.
32. Michnovicz JJ, Naganuma H, Hershcopf RJ, Bradlow HL, Fishman J. Increased urinary catechol excretion in female smokers. Steroids 1988; 52:69-83.
33. Millikan RC, Pittman GS, Newman B, Tse C-K J, Selmin O, Rockhill B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomark Prev 1998; 7:371-378.
34. Morabia A, Bernstein M, Héritier S, Khatchatrian N. Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 1996; 143:918-928.
35. Nomura A, Comstock GW, Tonascia JA. Epidemiologic characteristics of benign breast disease. Am J Epidemiol 1977; 105:505-512.
36. Page DL, Rogers LW. Combined histolopathologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992; 23:1095-1097.
37. Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 1993; 15:145-156.
38. Pastides H, Najjar MA, Kelsey JL. Estrogen replacement therapy and fibrocystic breast disease. Am J Prev Med 1987; 3:282-286.
39. Pfau W, O'Hare MJ, Grover PL, Phillips DH. Metabolic activation of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) to DNA binding species in human mammary epithelial cells. Carcinogenesis 1992; 13:907-909.
40. Philip PA, Rogers HJ, Millis RR, Rubens RD, Cartwright RA. Acetylator status and its relationship to breast cancer and other diseases of the breast. Eur J Cancer Clin Oncol 1987; 23:1701-1706.
41. Risch A, Wallace DM, Bathers S, Sim E. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 1995; 4:231-236.
42. Rohan TE, Cook MG, Baron JA. Cigarette smoking and benign proliferative epithelial disorders of the breast in women: a case-control study. J Epidemiol Commun Health 1989; 43:362-368.
43. Smith SJ, Deacon JM, Chilvers CE. Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group. Br J Cancer 1994; 70:112-119.
44. Swaminathan S, Frederickson SM, Hatcher JF. Metabolic activation of N-hydroxy-4-acetylaminobiphenyl by cultured human breast epithelial cell line MCF 10A. Carcinogenesis 1994; 15:611-617.
45. Talaska G, al-Juburi AZ, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA 1991; 88:5350-5354.
46. Thomas EJ, Edridge W, Weddell A, McGill A, McGarrigle HHG. The impact of cigarette smoking on the plasma concentrations of gonadotropins, ovarian steroids and androgens and upon the metabolism of oestrogens in the human female. Hum Reprod 1993; 8:1187-1193.
47. Vatsis KP, Martell KJ, Weber WW. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc Natl Acad Sci USA 1991; 88:6333-6337.
48. Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans DAP, Grant DM, et al. Nomenclature for N-acetyltransferases. Pharmacogenetics 1995; 5:1-17.
49. Vineis P, Bartsch H, Caparaso N, Harrington A, Kadlubar F, Landl M, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994; 369:154-156.
50. Wyshak G, Frisch RE, Albright NL, Albright TE, Schiff I. Cigarette smoking and benign breast disease [letter]. N Engl J Med 1988; 319:1736-1737.
51. Yamashita M, Wakabayashi K, Nagao M, Sato S, Yamaizumi Z, Takahashi M, et al. Detection of 2-amino-3-methylimidazor[4,5-f]quinoline in cigarette smoke condensate. Jpn J Cancer Res 1986; 77:419-422.